CRIS Curis

Curis is a long way from being a top notch Pharmaceutical company. I actually interviewed there for a scientist position about two years ago. I think they are working on excellent cancer pathways and I wager are going to get something past the FDA someday. Their best bet is to bring value to a narrow set of compounds then garner interest for a buyout of the company. I'm close to buying but wont buy more than a couple percent of my portfolio. It's purely speculative because they really need a compound to bring profits in the door. A big concern on this is the low volume and its danger of being de-listed from the NASDAQ.